Genmab — Juli 2023
-
Det gør det, @ JKY
-
Er lige nu i DH
-
Genmab Breaks Above 200-Day Moving Average - Bullish for GMAB
In trading on Friday, shares of Genmab A/S (Symbol: GMAB) crossed above their 200 day moving average of $39.58, changing hands as high as $39.70 per share. Genmab A/S shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of GMAB
(www.nasdaq.com)
-
lahn1. synes nu, at dit indlæg 21:55 var bedst
-
Lidt lidt ærgerligt, at børsen først åbner mandag morgen
-
Det synes jeg også. https://imgur.com/a/WXOd1T8
-
Johnson & Johnson Poised For A Muted Q2? https://www.proinvestor.com/investornyt/1015967/johnson-amp-johnson-poised-for-a-muted-q2
-
Antengene : Xpovio Approved In Hong Kong For Relapsed And/or Refractory Multiple Myeloma Treatment https://www.proinvestor.com/investornyt/1015963/antengene-xpovio-approved-in-hong-kong-for-relapsed-and-or-refractory-multiple-myeloma-treatment
-
Caribou Biosciences has reported new follow-up data from the dose-escalation portion of its ongoing Phase I ANTLER study, which is evaluating the allogeneic anti-CD19 CAR-T therapy CB-010 in 16 patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) https://firstwordpharma.com/story/5761039?aid=5761039
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind